126 related articles for article (PubMed ID: 8890967)
21. Interstitial irradiation of cerebral gliomas in childhood by permanently implanted 125-iodine--preliminary results.
Voges J; Sturm V; Berthold F; Pastyr O; Schlegel W; Lorenz WJ
Klin Padiatr; 1990; 202(4):270-4. PubMed ID: 2168501
[TBL] [Abstract][Full Text] [Related]
22. High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results.
Sharma DN; Joshi NP; Gandhi AK; Haresh KP; Gupta S; Julka PK; Rath GK
Brachytherapy; 2014; 13(5):481-7. PubMed ID: 25037912
[TBL] [Abstract][Full Text] [Related]
23. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
24. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
25. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.
Brada M; Thomas G; Elyan S; James N; Hines F; Ashley S; Marsh H; Bell BA; Stenning S
Br J Cancer; 1995 Jun; 71(6):1330-4. PubMed ID: 7779733
[TBL] [Abstract][Full Text] [Related]
26. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
27. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.
Mate TP; Gottesman JE; Hatton J; Gribble M; Van Hollebeke L
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):525-33. PubMed ID: 9635698
[TBL] [Abstract][Full Text] [Related]
28. Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.
Krauss DJ; Ye H; Martinez AA; Mitchell B; Sebastian E; Limbacher A; Gustafson GS
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):98-106. PubMed ID: 27979460
[TBL] [Abstract][Full Text] [Related]
29. [Radiotherapy of brain astrocytomas and oligodendrogliomas of the adult].
Mazeron JJ; Simon JM; Noël G; Proudhom MA; Renard A
Cancer Radiother; 2000 Nov; 4 Suppl 1():53s-66s. PubMed ID: 11194965
[TBL] [Abstract][Full Text] [Related]
30. Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer.
Siddiqui ZA; Gustafson GS; Ye H; Martinez AA; Mitchell B; Sebastian E; Limbacher A; Krauss DJ
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1038-1044. PubMed ID: 30771408
[TBL] [Abstract][Full Text] [Related]
31. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
[TBL] [Abstract][Full Text] [Related]
32. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
33. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.
Forrest JL; Ackerman I; Barbera L; Barnes EA; Davidson M; Kiss A; Thomas G
Int J Gynecol Cancer; 2010 Aug; 20(6):1074-8. PubMed ID: 20683420
[TBL] [Abstract][Full Text] [Related]
34. High dose rate brachytherapy for carcinoma of the oral tongue.
Leung TW; Wong VY; Wong CM; Tung SY; Lui CM; Leung LC; O SK
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1113-20. PubMed ID: 9392552
[TBL] [Abstract][Full Text] [Related]
35. Palliative interstitial HDR brachytherapy for recurrent rectal cancer. Implantation techniques and results.
Kolotas C; Röddiger S; Strassmann G; Martin T; Tselis N; Aebersold DM; Baltas D; Zamboglou N
Strahlenther Onkol; 2003 Jul; 179(7):458-63. PubMed ID: 12835882
[TBL] [Abstract][Full Text] [Related]
36. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
37. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
38. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results.
Hsu WL; Wu CJ; Jen YM; Yen SH; Lin KT; Ger LP; Kim RY
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1425-31. PubMed ID: 7635783
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?
Shakespeare TP; Lim KH; Lee KM; Back MF; Mukherjee R; Lu JD;
Int J Gynecol Cancer; 2006; 16(1):277-82. PubMed ID: 16445645
[TBL] [Abstract][Full Text] [Related]
40. The effect of waiting for radiotherapy for grade III/IV gliomas.
Do V; Gebski V; Barton MB
Radiother Oncol; 2000 Nov; 57(2):131-6. PubMed ID: 11054516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
